Abstract 1270: Potential metabolic and molecular mechanisms of black raspberry-mediated oral cancer chemoprevention

Author(s):  
Steve Oghumu ◽  
Thomas J. Knobloch ◽  
Logan C. Weghorst ◽  
Lei Bruschweiler-Li ◽  
Cheng Wang ◽  
...  
2011 ◽  
Vol 2011 ◽  
pp. 1-10 ◽  
Author(s):  
Takuji Tanaka ◽  
Mayu Tanaka ◽  
Takahiro Tanaka

Oral cancer is one of the major global threats to public health. The development of oral cancer is a tobacco-related multistep and multifocal process involving field cancerization and carcinogenesis. The rationale for molecular-targeted prevention of oral cancer is promising. Biomarkers of genomic instability, including aneuploidy and allelic imbalance, are possible to measure the cancer risk of oral premalignancies. Understanding of the biology of oral carcinogenesis will yield important advances for detecting high-risk patients, monitoring preventive interventions, and assessing cancer risk and pharmacogenomics. In addition, novel chemopreventive agents based on molecular mechanisms and targets against oral cancers will be derived from studies using appropriate animal carcinogenesis models. New approaches, such as molecular-targeted agents and agent combinations in high-risk oral individuals, are undoubtedly needed to reduce the devastating worldwide consequences of oral malignancy.


Head & Neck ◽  
2021 ◽  
Author(s):  
Rolando R. Rosas ◽  
Kristine M. Nachbor ◽  
Nathan Handley ◽  
Grant Mathison ◽  
Beverly R. Wuertz ◽  
...  

2013 ◽  
Vol 6 (5) ◽  
pp. 375-378 ◽  
Author(s):  
William N. William ◽  
Vassiliki A. Papadimitrakopoulou

2020 ◽  
Vol 21 (21) ◽  
pp. 8104
Author(s):  
Ru-Hsiu Cheng ◽  
Yi-Ping Wang ◽  
Julia Yu-Fong Chang ◽  
Yu-Hwa Pan ◽  
Mei-Chi Chang ◽  
...  

Betel quid (BQ) chewing increased the risk of oral cancer and oral submucous fibrosis (OSMF), an oral premalignant disorder (OPMD) with malignant transformation potential. BQ components such as areca nut (AN), trauma by coarse AN fiber, catechin, copper, alkaloids, stimulated reactive oxygen species (ROS), inflammation and cytotoxicity are suggested to be the contributing factors. They may induce tissue inflammation, proliferation of fibroblasts and collagen deposition, myofibroblast differentiation and contraction, collagen cross-links and inhibit collagen phagocytosis, finally leading to the development of OSMF and oral cancer. These events are mediated by BQ components-induced changes of extracellular matrix (ECM) turnover via regulation of TGF-β1, plasminogen activator inhibitor-1 (PAI-1), cystatin, lysyl oxidase (LOX) and tissue inhibitors of metalloproteinases (TIMPs) and metalloproteinases (MMPs). Genetic susceptibility is also involved in these disease processes. Further understanding the molecular mechanisms of BQ-induced OSMF and oral cancer can be helpful for future disease prevention and treatment.


2019 ◽  
pp. 29-80 ◽  
Author(s):  
Prashanth Panta ◽  
Bramanandam Manavathi ◽  
Siddavaram Nagini

ISRN Oncology ◽  
2011 ◽  
Vol 2011 ◽  
pp. 1-7 ◽  
Author(s):  
Ui-Lyong Lee ◽  
Sung-Weon Choi

Chemoprevention is a relatively novel and promising approach for controlling cancer that uses specific natural products or synthetic agents to suppress, reverse, or prevent premalignancy before transformation into invasive cancer. Oral cavity squamous cell carcinoma (OCSCC) represents a large, worldwide health burden with approximately 274,000 cases diagnosed annually worldwide. Smoking and alcohol consumption are major inducers of OCSCC. Recently, the human papilloma virus was also shown to potentially be an etiologic factor. Due to its easily identifiable risk factors and the presence of premalignant regions, oral cancer makes a good candidate for chemoprevention. Green tea is the most widely consumed beverage in the world, and it has received considerable attention because of its abundant, scientifically proven, beneficial effects on human health. In this review, we discuss the role of green tea in oral cancer chemoprevention with regard to the multiple molecular mechanisms proposed in various in vitro, in vivo, and clinical trials.


2007 ◽  
Vol 24 (4) ◽  
pp. 728-737 ◽  
Author(s):  
Susan R. Mallery ◽  
Gary D. Stoner ◽  
Peter E. Larsen ◽  
Henry W. Fields ◽  
Kapila A. Rodrigo ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document